The cyclooxygenase-2 enzyme (COX-2) is involved in prostaglandin biosynthesis and
thus plays a significant role in the process of inflammation. Different types of natural
compounds can affect the COX-2 enzymatic activity [1]. In recent years it has also
been suggested that COX-2 is involved in cancer development [2]. As many natural compounds
are present in the human diet this study has focused on discovery of natural COX-2
inhibitors present in food. A number of human fecal water samples (the aqueous phase
of feces) from vegetarians were collected and assessed for effects on COX-2 enzymatic
activity and also for effects on protein expression level in human colon cancer cells
(HT-29). Of 14 samples analyzed, 13 decreased COX-2 protein levels in the cells (19–63%
inhibition) [3]. Most samples also significantly decreased prostaglandin (PGE2) production
in HT-29 cells [3]. Solid phase extraction was performed to trace the activity of
the fecal water samples. The resulting water fraction was found to be responsible
for the inhibitory activity of the samples, suggesting that the active compounds are
most likely polar in nature. The chemical content of fecal water was analyzed using
chromatographic techniques. Gas chromatography-mass spectrometry was used to study
the content of the fecal water, with an emphasis on finding phenolic compounds, whereas
nuclear magnetic resonance (NMR) was used to obtain an overview of the total fecal
water content. The NMR metabolite profiles of vegetarian fecal water samples were
very similar, suggesting that the colonic content of the individuals in the study
population were similar in composition. A variety of compounds were identified including
several phenolic compounds, amino acids and fatty acids. To the best of our knowledge,
the use of NMR as a tool in studying colonic contents represents a new approach that
would potentially be very useful in colon cancer research.
References: 1. Perera, P. et al. (2000), Bioactive compounds from natural sources, Tringali, C., Ed., Taylor & Francis:
London, pp. 433–472. 2. Soslow, R.A. et al. (2000), Cancer 89: 2637–2645. 3. Karlsson, P.C. et al. (2005), J. Nutr. 135: 2343–2349.